#GI25 @ASCO 
📌 Access to timely biomarker testing remains a challenge for 1L #mCRC 
➡️ our review confirmed RAS-BRAF⛔️ available at MO consult 80% of the time
➡️ strategies to improve timely biomarker testing are needed 🇨🇦 
Congrats to our @BCCancer resident Dr Tae Hoon Lee 👏 
@TharaniK001 @OncoAlert